288 related articles for article (PubMed ID: 25199815)
1. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.
Lim HK; Baek JH; Lee JH; Kim WB; Kim TY; Shong YK; Hong SJ
Eur Radiol; 2015 Jan; 25(1):163-70. PubMed ID: 25199815
[TBL] [Abstract][Full Text] [Related]
2. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
Chung SR; Baek JH; Choi YJ; Lee JH
Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review.
Yoo RE; Kim JH; Paeng JC; Park YJ
Medicine (Baltimore); 2018 Mar; 97(9):e0003. PubMed ID: 29489641
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.
Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y
Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonography-guided radiofrequency ablation for the treatment of T2N0M0 papillary thyroid carcinoma: a preliminary study.
Xiao J; Zhang Y; Zhang M; Xie F; Yan L; Luo Y; Tang J
Int J Hyperthermia; 2021; 38(1):402-408. PubMed ID: 33719861
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma.
Lee SJ; Jung SL; Kim BS; Ahn KJ; Choi HS; Lim DJ; Kim MH; Bae JS; Kim MS; Jung CK; Chong SM
Korean J Radiol; 2014; 15(6):817-26. PubMed ID: 25469095
[TBL] [Abstract][Full Text] [Related]
9. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation.
Baek JH; Kim YS; Sung JY; Choi H; Lee JH
AJR Am J Roentgenol; 2011 Aug; 197(2):W331-6. PubMed ID: 21785061
[TBL] [Abstract][Full Text] [Related]
10. Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: A prospective study.
Yue W; Chen L; Wang S; Yu S
Int J Hyperthermia; 2015 Jun; 31(4):403-8. PubMed ID: 25792224
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer.
Papini E; Bizzarri G; Bianchini A; Valle D; Misischi I; Guglielmi R; Salvatori M; Solbiati L; Crescenzi A; Pacella CM; Gharib H
J Clin Endocrinol Metab; 2013 Jan; 98(1):E92-7. PubMed ID: 23150695
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
[No Abstract] [Full Text] [Related]
13. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: A comparative study.
Xiao J; Zhang Y; Zhang M; Lan Y; Yan L; Luo Y; Tang J
Clin Endocrinol (Oxf); 2021 Apr; 94(4):684-691. PubMed ID: 33128786
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma.
Wang L; Ge M; Xu D; Chen L; Qian C; Shi K; Liu J; Chen Y
J Cancer Res Ther; 2014 Nov; 10 Suppl():C144-9. PubMed ID: 25450273
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma.
Monchik JM; Donatini G; Iannuccilli J; Dupuy DE
Ann Surg; 2006 Aug; 244(2):296-304. PubMed ID: 16858194
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma: A Prospective Study.
Zhang M; Luo Y; Zhang Y; Tang J
Thyroid; 2016 Nov; 26(11):1581-1587. PubMed ID: 27445090
[TBL] [Abstract][Full Text] [Related]
18. US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population.
Lim HK; Cho SJ; Baek JH; Lee KD; Son CW; Son JM; Baek SM
Korean J Radiol; 2019 Dec; 20(12):1653-1661. PubMed ID: 31854153
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy and Safety of Radiofrequency Ablation for Bilateral Papillary Thyroid Microcarcinoma.
Yan L; Zhang M; Song Q; Xiao J; Zhang Y; Luo Y
Front Endocrinol (Lausanne); 2021; 12():663636. PubMed ID: 34177804
[TBL] [Abstract][Full Text] [Related]
20. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
